Skip to main content

Table 1 Clinicopathological features of colorectal cancer with PTEN alteration

From: A comprehensive analysis of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) loss in colorectal cancer

  

IHC

Methylation

DNA copy number

  

Loss

Intact

p

Hyper

Normal

p

Decrease

Normal

p

 

Case no.(%)

68(34.3)

130(65.7)

 

54(27.3)

144(72.7)

 

36(18.2)

162(81.8)

 

Gender

 Male

127(64.1)

43(33.9)

84(66.1)

0.877

36(28.3)

91(71.7)

0.740

15(11.8)

112(88.2)

0.002

 Female

71(35.9)

25(35.2)

46(64.8)

 

18(25.4)

53(74.6)

 

21(29.6)

50(70.4)

 

Location

 Rectum

61(30.8)

17(27.9)

44(72.1)

0.200

13(21.3)

48(78.7)

0.209

11(18.0)

50(82.0)

0.971

 Colon

137(69.2)

51(37.2)

86(62.8)

 

41(29.9)

96(70.1)

 

25(18.2)

112(81.8)

 

TNM Stage

 I

50(25.3)

10(20.0)

40(80.0)

0.001

18(36.0)

32(64.0)

0.354

11(22.0)

39(78.0)

0.446

 II

48(24.2)

13(27.1)

35(72.9)

 

11(22.9)

37(77.1)

 

5(10.4)

43(89.6)

 

 III

49(24.7)

16(32.7)

33(67.3)

 

14(28.6)

35(71.4)

 

10(20.4)

39(79.6)

 

 IV

51(25.8)

29(56.9)

22(43.1)

 

11(21.6)

40(78.4)

 

10(19.6)

41(80.4)

 

CEA level

 High

68(34.3)

31(45.6)

37(54.4)

0.019

19(27.9)

49(72.1)

0.879

14(20.6)

54(79.4)

0.525

 Normal

130(65.7)

37(28.5)

93(71.5)

 

35(26.9)

95(73.1)

 

22(16.9)

108(83.1)

 

Differentiation

 Poor

14(7.1)

2(14.3)

14(85.7)

0.145

5(35.7)

9(64.3)

0.535

3(21.4)

11(78.6)

0.722

 Mod/well

184(92.9)

66(35.9)

118(64.1)

 

9(26.2)

135(73.4)

 

33(17.9)

151(82.1)

 

LVI

 Present

49(24.7)

21(42.9)

28(57.1)

0.148

14(28.6)

35(71.4)

0.814

11(22.4)

38(77.6)

0.372

 Absent

149(75.3)

47(31.5)

102(68.5)

 

40(26.8)

109(73.2)

 

25(16.8)

124(83.2)

 

Mucinous histology

 Present

20(10.1)

8(40.0)

12(60.0)

0.574

4(20.0)

16(80.0)

0.441

4(20.0)

16(80.0)

0.824

 Absent

178(89.9)

60(33.7)

118(66.3)

 

50(28.1)

128(71.9)

 

32(18.0)

146(82.0)

 
  1. Lymphovascular invasion; numbers in parentheses are percentages